Durable remission of inoperable liver metastasis from rectal cancer after hepatic arterial infusion of oxaliplatin and 5-fluorouracil in combination with intravenous cetuximab.
暂无分享,去创建一个
B. Neyns | M. de Ridder | J. De Grève | M. Aerts | G. Delvaux | K. Van Bael
[1] C. Compton,et al. Colon and Rectum , 2012 .
[2] N. Kemeny,et al. Role of adjuvant therapy after resection of colorectal cancer liver metastases. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] R. Pearson,et al. Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer , 2010 .
[4] S. Mocellin,et al. Fluoropyrimidine-HAI (hepatic arterial infusion) versus systemic chemotherapy (SCT) for unresectable liver metastases from colorectal cancer. , 2009, The Cochrane database of systematic reviews.
[5] M. Ducreux,et al. Patients with initially unresectable colorectal liver metastases: is there a possibility of cure? , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] B. Neyns,et al. Cetuximab with hepatic arterial infusion of chemotherapy for the treatment of colorectal cancer liver metastases. , 2008, Anticancer research.
[7] W. Scheithauer,et al. Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study , 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] Thomas Gruenberger,et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial , 2008, The Lancet.
[9] S. Mocellin,et al. Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer: the end of an era? , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] Yuman Fong,et al. Actual 10-year survival after resection of colorectal liver metastases defines cure. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] Franco Berrino,et al. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. , 2007, The Lancet. Oncology.
[12] B. Neyns,et al. Techniques for the placement of hepatic artery catheters for regional chemotherapy in unresectable liver metastases. , 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[13] J. Ferlay,et al. Estimates of the cancer incidence and mortality in Europe in 2006. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.
[14] B. Neyns,et al. Hepatic arterial infusion of oxaliplatin and L-folinic acid-modulated 5-fluorouracil for colorectal cancer liver metastases. , 2006, Anticancer research.
[15] R. Goldberg,et al. Systemic therapy for metastatic colorectal cancer: current options, current evidence. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] Jürgen Weitz,et al. Colorectal cancer , 2005, The Lancet.
[17] A. Patchefsky,et al. Case report 3 , 1976, Skeletal Radiology.
[18] D. Kerr,et al. Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial , 2003, The Lancet.
[19] C. Compton,et al. AJCC Cancer Staging Manual , 2002, Springer New York.